MARKET

BCPC

BCPC

Balchem
NASDAQ

Real-time Quotes | Nasdaq Last Sale

140.02
+1.57
+1.13%
After Hours: 140.02 0 0.00% 16:19 09/17 EDT
OPEN
138.57
PREV CLOSE
138.45
HIGH
141.92
LOW
136.93
VOLUME
480.38K
TURNOVER
--
52 WEEK HIGH
142.46
52 WEEK LOW
92.60
MARKET CAP
4.53B
P/E (TTM)
50.77
1D
5D
1M
3M
1Y
5Y
APG All Pensions Group NV Buys Steris PLC, Wells Fargo, TransUnion, Sells Citigroup Inc, ...
GuruFocus News · 08/16 21:38
AzurRx BioPharma Announces Appointment of Terry Coelho to its Board of Directors
AzurRx expands Board of Directors to seven members with new appointmentBOCA RATON, Fla., Aug. 16, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (“AzurRx” or the “Company”) (NASDAQ: AZRX), a company specializing in the development of targeted non-systemic...
GlobeNewswire · 08/16 12:00
Benzinga's Top Ratings Upgrades, Downgrades For August 2, 2021
 
Benzinga · 08/02 14:23
10 Biggest Price Target Changes For Monday
Raymond James raised Edwards Lifesciences Corporation (NYSE: EW) price target from $101 to $122. Edwards Lifesciences shares gained 0.6% to close at $112.27 on Friday.
Benzinga · 08/02 11:51
Stephens & Co. Downgrades Balchem to Equal-Weight, Raises Price Target to $145
Stephens & Co. analyst Mark Connelly downgrades Balchem (NASDAQ:BCPC) from Overweight to Equal-Weight and raises the price target from $140 to $145.
Benzinga · 08/02 11:23
HC Wainwright & Co. Upgrades Balchem
HC Wainwright & Co. analyst Raghuram Selvaraju upgrades Balchem (NASDAQ:BCPC)
Benzinga · 08/02 10:37
--Stephens Downgrades Balchem to Equal-Weight From Overweight, Adjusts Price Target to $145 From $140
MT Newswires · 08/02 09:07
--HC Wainwright Adjusts Balchem's Price Target to $160 From $145, Reiterates Buy Rating
MT Newswires · 08/02 07:12
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of BCPC. Analyze the recent business situations of Balchem through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 4 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average BCPC stock price target is 150.75 with a high estimate of 160.00 and a low estimate of 140.00.
EPS
Institutional Holdings
Institutions: 346
Institutional Holdings: 30.01M
% Owned: 92.71%
Shares Outstanding: 32.37M
TypeInstitutionsShares
Increased
87
1.58M
New
17
52.68K
Decreased
89
1.32M
Sold Out
18
55.57K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Food Processing
+0.06%
Food & Tobacco
-0.29%
Key Executives
Chairman/President/Chief Executive Officer/Director
Theodore Harris
Chief Financial Officer
Martin Bengtsson
Senior Vice President/General Manager
James Hyde
Chief Accounting Officer
William Backus
General Counsel/Secretary
Mark Stach
Lead Director/Independent Director
John Televantos
Director
Kathleen Fish
Independent Director
David Fischer
Independent Director
Daniel Knutson
Independent Director
Joyce Lee
Independent Director
Perry Premdas
Independent Director
Matthew Wineinger
Declaration Date
Dividend Per Share
Ex-Div Date
12/17/2020
Dividend USD 0.58
12/24/2020
12/18/2019
Dividend USD 0.52
12/27/2019
12/12/2018
Dividend USD 0.47
12/24/2018
12/13/2017
Dividend USD 0.42
12/26/2017
12/13/2016
Dividend USD 0.38
12/22/2016
12/15/2015
Dividend USD 0.34
12/23/2015
12/19/2014
Dividend USD 0.3
12/24/2014
12/13/2013
Dividend USD 0.26
12/19/2013
11/30/2012
Dividend USD 0.22
12/12/2012
12/05/2011
Dividend USD 0.18
12/12/2011
12/10/2010
Dividend USD 0.15
12/17/2010
12/09/2009
Dividend USD 0.11
12/28/2009
--
Dividend USD 0.11
12/18/2008
--
Dividend USD 0.11
12/18/2007
--
Dividend USD 0.09
12/27/2006
--
Dividend USD 0.09
12/28/2005
--
Dividend USD 0.09
12/28/2004
--
Dividend USD 0.08
12/24/2003
--
Dividend USD 0.08
12/23/2002
--
Dividend USD 0.065
12/21/2001
  • All
  • Financials
  • Insiders
More
About BCPC
Balchem Corporation is engaged in the development, manufacture and marketing of specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, medical sterilization and industrial markets. The Company operates in four segments: Human Nutrition & Health, Animal Nutrition & Health, Specialty Products and Industrial Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry, providing solutions in powder, solid and liquid flavor delivery systems, spray dried emulsified powder systems and cereal systems. The Animal Nutrition & Health segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to basic choline chloride. The Specialty Products segment sells ethylene oxide as a sterilant gas primarily for use in the healthcare industry. The Industrial Products segment includes the manufacture and sale of methylamines.

Webull offers kinds of Balchem Corporation stock information, including NASDAQ:BCPC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BCPC stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading BCPC stock methods without spending real money on the virtual paper trading platform.